Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FEGSM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,754
Award facts
- Contract value 100% obligated
- $42,753.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $42,753.53 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen 2 mL, a prescription medication used to treat autoimmune conditions. This firm fixed-price delivery order, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive award under AmerisourceBergen's existing pharmaceutical supply contract. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania.
This delivery order is executed under AmerisourceBergen Drug Corp's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the contractor to supply a comprehensive range of pharmaceuticals and medical supplies to military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contract reflects the company's established capability to fulfill federal pharmaceutical supply requirements through its extensive portfolio of brand-name and generic medications across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FEGSM?
SPE2DB25FEGSM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 22, 2025.
How much is contract SPE2DB25FEGSM worth?
The government has obligated $42,754 on SPE2DB25FEGSM.
Is contract SPE2DB25FEGSM an order under another contract?
Yes. SPE2DB25FEGSM is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEGSM competed?
The extent of competition for SPE2DB25FEGSM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award